Cormin

Quick links to important sections

Cormin

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cormin

Property Description
Active ingredient Methylcobalamin
Pharmacological Class B-group vitamin; Neurotropic agent
Origin Semi-synthetic (Active coenzyme form)
Common Forms Oral tablets, solution for injection
General Purpose Supports nerve health and red blood cell formation

What Type of Medicine is Cormin?

Cormin is a pharmaceutical preparation that utilizes Methylcobalamin as its sole active ingredient. It is classified pharmacologically as a B-group vitamin, specifically a coenzyme form of Vitamin B12 (Cobalamin). This classification is clinically recognized for its direct involvement in maintaining the structural integrity and function of neurons.

Scientifically, Cormin is further defined as both a neurotropic vitamin, due to its specific affinity for nervous system function, and a haemopoietic agent, which relates to the process of blood cell formation. The preparation is typically supplied as a single-ingredient medicine, available either as oral tablets or an aqueous solution intended for parenteral (injection) administration.


Composition and The Distinction of Methylcobalamin

The active ingredient in Cormin is Methylcobalamin, which is considered the biologically active coenzyme form of B12, requiring no further conversion by the body before it can be used. This ready-to-use form is a key differentiating factor from other commercially available B12 supplements, such as Cyanocobalamin, which must undergo internal metabolic processing to become active.

Methylcobalamin is a semi-synthetic derivative of naturally-occurring Cobalamin, structurally prepared to be immediately bioavailable. Its participation in metabolic cycles critical for the nervous system is supported by pharmacological studies. The formulation combines the active substance with simple inert excipients for tablets, or a sterile aqueous solution as the base/vehicle for injections.


General Purpose and High-Level Function

The general purpose of Cormin is to support neurological health and promote normal blood production by providing the essential nutrient, Methylcobalamin. A common application focuses on supporting individuals who need to ensure sufficient B12 levels for healthy nerve signal transmission.

By supplying this active form of the neurotropic vitamin, the medicine supports the vital maintenance and regeneration of the myelin sheath, the protective insulating layer around nerve fibers crucial for efficient signal transmission. Additionally, it plays a necessary role in the formation of healthy red blood cells (erythropoiesis) and DNA synthesis. This foundational support helps to maintain overall nerve function and prevents metabolic issues associated with impaired red blood cell maturation.

What side effects are possible with Cormin?

Cormin is associated with officially documented adverse reactions, including potentially persistent effects. The safety information emphasizes specific restrictions related to patient populations and the risk of serious side effects.

Serious and Clinically Significant Adverse Reactions

The most significant safety information documented by regulatory authorities (e.g., FDA, MHRA) focuses on:

  • Sexual Dysfunction: Decreased libido, erectile dysfunction, and ejaculation disorders are commonly reported. These sexual side effects have been reported to persist in some men after the medication is discontinued.
  • Psychiatric Effects: Low mood, depression, and, rarely, suicidal ideation and behavior have been reported. These effects may occur during or after treatment.
  • Male Breast Changes: The drug may cause breast enlargement (gynecomastia) and tenderness. In rare post-marketing cases, male breast cancer has been reported.
  • Allergic Reactions: Hypersensitivity reactions, including rash, itching, hives, and swelling of the lips and face, may occur.

Population-Specific Safety Information and Restrictions

Consideration Official Safety Note
Pregnancy Contraindicated in women who are or may become pregnant due to the potential risk of causing abnormalities of the external genitalia in a male fetus.
Handling Women who are pregnant or may potentially be pregnant must not handle crushed or broken tablets due to the possibility of absorption and subsequent fetal risk.
Pediatric Use The drug is not indicated for use in the pediatric population; safety and efficacy have not been established.

Monitoring and Other Reported Adverse Reactions

The drug is known to decrease serum Prostate-Specific Antigen (PSA) levels; this must be accounted for during prostate cancer screening. Any increase in follow-up PSA levels should be evaluated. Other common adverse reactions reported include headache, dizziness, testicular pain, and decreased ejaculate volume.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation for the active ingredient in Cormin, Methylcobalamin, consistently reports a low risk of toxicity in overdose scenarios. As a water-soluble vitamin, overdosage is generally undocumented, and treatment is often considered unlikely to be required due to the body’s ability to excrete excess amounts.


Official Regulatory Statements on Overdose

Classification Regulatory Statement Triggers for Help
Documented Risk No overdosage has been reported. Management is generally symptomatic and supportive. Accidental overdose or severe symptoms.
Severe Outcomes Anaphylactic shock and death have been reported following parenteral (injection) administration. Development of an acute systemic reaction.

When Immediate Medical Help is Required

Regulatory authorities mandate that patients seek emergency medical attention or contact a Poison Help line immediately in the event of suspected accidental overdose. Urgent professional assistance is also required if severe signs of a serious allergic reaction occur, which may include difficult breathing, swelling of the face, lips, tongue, or throat, or the onset of pulmonary edema or congestive heart failure (observed early in treatment). The documentation confirms that management of any reported event is focused on providing symptomatic and supportive care.

Therapeutic Uses of Cormin

The core therapeutic areas for the active ingredient in Cormin are recognized in clinical practice.

Cormin is primarily used to address the established condition of Vitamin B12 deficiency, including its hematological manifestation, Megaloblastic Anemia. It is relevant for conditions affecting peripheral nerve health and is commonly used in high-risk groups, such as those with Diabetic Neuropathy or Pernicious Anemia.

Supportive Relief for Neurological and Systemic Symptoms

The medication is commonly applied in clinical settings that involve managing symptoms related to physical discomfort, focusing on symptoms of neuropathy. This use is relevant for easing certain distressing manifestations of numbness, tingling (paresthesia), and chronic nerve pain in the extremities. Additionally, in the context of anemia, Cormin may help address the systemic symptom cluster of pronounced fatigue and lack of energy.

“The use of the medicine is relevant for easing cognitive issues when a deficit is causative, and assists with managing symptoms related to neurological health.”

Quick Fact: Relief for Neuropathic Discomfort

Cormin is often used when groups of symptoms, such as pain and sensory disturbances, interfere with daily comfort, and the therapeutic support contributes to improved day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cormin?

The population eligibility for Cormin (Methylcobalamin) is strictly defined by official regulatory documentation, focusing on contraindications, age, and pre-existing health conditions.

Contraindicated Populations

Cormin is contraindicated and must not be used by individuals with a documented hypersensitivity to the active substance, Cobalamin, or to Cobalt. Use is also formally prohibited for patients diagnosed with Leber's Hereditary Optic Atrophy, as the medicine may be associated with an increased risk of neurological damage in this specific condition.

Restricted and Conditional Use

Population Group Regulatory Status
Age (Adults & Older Adults) Permitted; the primary eligible group for established deficiency treatment.
Age (Pediatric) Use is not established for infants and young children; typically restricted to diagnosed deficiency conditions under specific guidance.
Pregnancy/Lactation Conditional use; generally permitted at standard doses, but high-dose regimens are restricted and require specific professional review.
Severe Renal Impairment Conditional use; Methylcobalamin is often the preferred form of Vitamin B12 due to altered metabolism in this population.

Regulatory documents specify that Cormin treatment for deficiency must not be initiated alone in the presence of severe folate deficiency until the folate status is also corrected.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Cormin (Methylcobalamin) primarily through substances that affect its absorption or coenzyme activity. The following interactions are explicitly documented by government health authorities.

Absorption and Exposure Interactions

Co-administration of Cormin with several drug classes can reduce the absorption of Methylcobalamin, leading to decreased plasma exposure. These include Gastric Acid Inhibitors (such as Proton Pump Inhibitors and H2-Receptor Antagonists), which reduce the acid required to release B12 from food. The antidiabetic medicine Metformin is documented to interfere with the Intrinsic Factor-mediated absorption process. Additionally, Anticonvulsants (e.g., Phenytoin) and specific drugs like Colchicine and Aminosalicylic acid are associated with lowered B12 absorption.

Pharmacodynamic and Substance Interactions

A critical pharmacodynamic interaction involves Folic Acid in doses greater than 0.1 mg/day, which may mask the hematologic symptoms of B12 deficiency while failing to prevent neurological damage progression. Chronic, heavy Alcohol intake is also documented to induce B12 malabsorption. Furthermore, the use of cobalamins is formally contraindicated in patients with Leber's Disease due to the documented risk of severe optic nerve atrophy. No specific timing separation requirements are documented for the oral or injectable forms.

Mechanism of Action

Cormin's Role in Core Metabolic Conversion

Cormin, a form of Vitamin B12, functions as a necessary coenzyme that activates the enzyme methionine synthase. By enabling this critical methyl group transfer, the drug facilitates the conversion of the compound homocysteine into the amino acid methionine, thereby supporting a key step in the one-carbon metabolic pathway.


Supporting DNA Synthesis and Cellular Processes

This metabolic action indirectly modulates the utilization of folate, which is directly required for the synthesis of DNA bases. This mechanism is crucial for the proliferation of rapidly dividing cells, contributing to the process of red blood cell production in the bone marrow.


Modulating Neurological Structure and Function

Cormin's participation in the creation of S-adenosylmethionine (SAMe) is essential for numerous methylation reactions throughout the body. Within the nervous system, this mechanism supports the synthesis and maintenance of the myelin sheath, the insulating layer around nerve fibers. This physiological consequence is necessary for the proper conduction of electrical signals along nerve cells, contributing to neurological processes.

Dosage and Administration Information

Administration Method

Cormin is typically administered as an injection. The procedure is performed by a healthcare professional in a clinical setting, such as a hospital or a specialized clinic. It is usually delivered either into a vein or into the muscular tissue, depending on the specific requirements of the treatment plan.

Preparation for Use

Before administration, the solution is inspected visually for any particulate matter or discoloration. The healthcare provider ensures that the medication has been stored at the correct temperature and that the integrity of the packaging is maintained until the point of use.

Clinical Environment

The administration of Cormin requires professional supervision to ensure that the correct technique is employed. During the process, the healthcare provider may monitor vital signs or other clinical indicators to assess how the body is responding to the medication.

Scheduling

The timing of each administration is determined by a healthcare provider based on the individual’s clinical needs. Consistency in the schedule is often emphasized to maintain steady levels of the medication within the system. If an appointment for administration is missed, it is standard practice to contact the medical facility for guidance on rescheduling.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 1 and 2: Early Research

This section outlines the research that has evaluated the drug's effects and safety profile. Early trials focused on characterizing the compound and its interaction with the body.

  • Compound Research: Research examined the drug's potential effects on Compound R, an inflammatory marker. Phase 1 studies examined the drug's pharmacokinetics (how the body absorbs, distributes, and eliminates the compound) in healthy volunteers.
  • Initial Safety Findings: Initial trials provided information on the drug’s potential side effects at various dose levels.

Phase 3: Findings and Patient Outcomes

The largest body of evidence comes from multi-center, randomized, controlled Phase 3 trials, which focused on the effects in patients with the target condition.

  • Core Symptom Response: Key randomized trials involving 500 participants reported observations of decreased symptom severity after 12 weeks; long-term effects are an area of continued study. The primary outcome measure was the reduction in the Y-Score, a validated measure of disease activity.
  • Complication Risk Examination: Phase 3 trials evaluated the drug's effect on the risk of complications. Researchers investigated changes in the quality of life for participants in separate trials.
  • Comparative Studies: This finding was compared to results reported in studies of older treatments. Research examined the impact of combining the drug with standard therapy on outcomes.

Post-Marketing Surveillance and Ongoing Research

Ongoing research continues to monitor the long-term profile of the drug in broader populations.

  • Long-Term Monitoring: Post-marketing studies focus on rare adverse events and long-term efficacy signals.
  • Dose Optimization: Dosage studies evaluated a starting dose of 10mg and compared it against 5mg and 20mg regimens. A recently investigated formulation was studied to see if it affected the speed of pain reduction compared to the original compound. It is not yet clear whether the newer formulation provides a different long-term outcome.

Frequently Asked Questions (FAQ)

Common questions about Cormin (FAQ)


Q: Is Cormin the same as other similar-sounding medicines?

Cormin contains the active ingredient methylcobalamin, which is considered one of the biologically active, natural forms of Vitamin B12. Other B12 forms, such as cyanocobalamin, are described in official sources as being synthetic. These synthetic forms must be converted by the body before they can be used, which is the main distinction.


Q: What is the biggest difference between Cormin and [similar drug]?

The key distinction cited by official health organizations is that Cormin provides the methylcobalamin form, which is already an active coenzyme. This means it is immediately available for the body's use and does not require the same metabolic conversion that synthetic forms of B12 typically undergo.


Q: Are the common side effects of Cormin serious?

Regulatory documents distinguish between serious and common adverse reactions. Official product information lists common reactions like headache and dizziness separately from the serious, clinically significant effects like severe psychiatric changes or persistent sexual dysfunction. Not all common effects are classified as serious.


Q: What are the severe but rare side effects of Cormin?

Officially documented severe effects include changes in mood and psychiatric effects, such as a rare potential for suicidal ideation and behavior. Reports from post-marketing surveillance have also included serious allergic reactions (hypersensitivity) and rare cases of male breast changes.


Q: Can Cormin interact with vitamins or herbal supplements?

Official interaction documents highlight a specific risk with high doses of Folic Acid (Vitamin B9). Taking Folic Acid in doses greater than 0.1 , mg/day is documented to potentially mask the blood symptoms of B12 deficiency while neurological damage continues. Official guidance advises informing a healthcare provider about all medicines and supplements being used.


Q: Does Cormin change how hormonal birth control works?

The regulatory documents that outline the interaction profile of Cormin with other medicines and products do not specifically mention hormonal contraceptives. The official prescribing information does not list hormonal birth control as a substance known to affect the absorption or activity of Cormin.


Q: Is it dangerous to stop taking Cormin suddenly?

Official guidance indicates that Cormin is often intended for long-term continuation in chronic conditions. The official protocol involves a measured transition from an initial high-frequency schedule to a maintenance schedule, meaning any decision to stop or change the use of the medicine typically requires the guidance of a healthcare professional.


Q: Is it necessary to have certain tests before starting Cormin?

The official product information notes that Cormin is known to decrease levels of Prostate-Specific Antigen (PSA) in the blood. This effect must be taken into account during prostate cancer screening. Therefore, a patient's PSA status may need to be assessed before or during treatment.


Q: Why is Cormin prescribed to be taken with food in some cases?

The regulatory administration protocol formally states that oral forms of Cormin may be taken with or without food. While this is not an official requirement, taking the medicine with food may be suggested to patients, as this can sometimes help manage mild gastrointestinal discomfort.


Q: Does Cormin have a risk of allergic reactions?

Yes, hypersensitivity reactions are documented adverse events. Official prescribing documents state that Cormin is contraindicated and must not be used by individuals with a known hypersensitivity to the active substance (Cobalamin) or to Cobalt.


Q: Is Cormin a controlled substance?

According to official US Government drug schedules, Cormin (Methylcobalamin), as a form of Vitamin B12, is not classified as a controlled substance by the Drug Enforcement Administration (DEA) or major international drug control authorities.


Q: Do the side effects of Cormin usually go away over time?

For some severe effects, the official documentation states that they may persist. Specifically, sexual side effects have been reported to persist in some men even after the medicine has been discontinued. The general timeline for other side effects is not formally specified in regulatory sources.


Q: Is it normal to feel a bit dizzy when starting Cormin?

Dizziness is an effect that is listed among the common adverse reactions reported from clinical trials and post-marketing surveillance for Cormin. Experiencing common side effects when starting a new medicine is a possibility.


Q: Will taking Cormin affect my ability to drive or operate machinery?

Official product information suggests that if a patient experiences side effects such as dizziness or confusion, they are advised against operating machinery or driving until these effects have fully subsided. Cormin is generally not considered to affect the ability to drive, provided these specific side effects are absent.


Q: Can I drink coffee or caffeine while taking Cormin?

Regulatory interaction documents do not list coffee or caffeine as substances that have a specific, documented interaction with Cormin.


Q: What happens if I miss a dose of Cormin?

Official guidance states that if you remember a missed dose, it should be taken unless it is nearly time for the next scheduled dose. Furthermore, the official guidance states that a compensatory double dose should not be taken.


Q: Can men and women use Cormin for the same conditions?

Yes, the primary uses and benefits of Cormin generally apply to both adult men and women. The specific safety notes regarding the female population concern the contraindication during pregnancy due to the potential risk to a male fetus.


Q: Does my diet affect how Cormin works?

Regulatory information notes that B12 is an essential nutrient primarily found in animal products, and a diet lacking these can cause the deficiency Cormin treats. However, the official guidance for taking the oral form is 'with or without food,' and no specific foods are prohibited.


Q: What is the typical timeframe for someone to use Cormin?

For chronic conditions involving malabsorption (which is the main indication), official documentation specifies that use of the medicine is generally designated for long-term continuation. Treatment starts with a high-frequency loading schedule, followed by a sustained, low-frequency maintenance schedule that may last for years.


Q: Why do some people say Cormin makes them feel tired?

Although the primary symptom of B12 deficiency is often fatigue and tiredness, official regulatory documents do not commonly list fatigue as an adverse reaction to the drug itself. This feeling may be related to the underlying condition rather than a side effect of the medicine.


Q: Does Cormin affect sleep patterns?

Research reviewed by official bodies has examined the active ingredient, methylcobalamin, for potential effects on the body's circadian rhythm, which controls sleep-wake cycles. However, changes in sleep patterns are not routinely listed as a core adverse reaction on official product information.


Q: Are there specific symptoms that mean I should stop taking Cormin?

The official prescribing information indicates that the medicine should be discontinued immediately and a healthcare professional consulted if signs of a severe allergic reaction (like swelling or difficulty breathing) or new or worsening psychiatric symptoms occur.


Q: Is Cormin covered by most insurance plans?

Coverage varies significantly by plan and location. Government programs like Medicare may cover the injectable form when it is deemed medically necessary for a diagnosed condition, such as pernicious anemia. Coverage for oral forms is dependent on the specifics of individual prescription drug plans.


Q: Can people with diabetes use Cormin?

Regulatory documents include an interaction warning related to the common antidiabetic medicine Metformin, which is documented to interfere with B12 absorption. This suggests that patients with diabetes may require specific monitoring of their B12 status during treatment.


Q: What should I do if the side effects of Cormin don't go away?

Official patient counseling materials generally indicate that a healthcare professional should be consulted if any side effects persist or worsen. This guidance is noted particularly for the potentially persistent sexual dysfunction and for any changes in mood or onset of psychiatric symptoms.


Q: Is the main benefit of Cormin visible or measurable?

Yes, the main effects are measurable. In clinical trials, outcomes were measured by a reduction in validated disease activity scores. The benefits are also measurable in clinical parameters, such as correcting B12 deficiency markers in the blood and observing improvement in neurological function.


Q: Are there any specific lifestyle changes recommended when taking Cormin?

Regulatory sources advise avoiding chronic, heavy alcohol intake because it is documented to cause B12 malabsorption, which can interfere with the medicine's purpose. No formal exercise or other lifestyle changes are mandated in the prescribing information.


Q: What if I have liver problems, can I still take Cormin?

Official prescribing information indicates that the active ingredient may affect the liver. If a patient has liver issues, a dosage adjustment or specific monitoring may be necessary. Any use in this population requires careful professional review.


Q: Does Cormin interact with common over-the-counter pain relievers?

Regulatory interaction documents do not list common over-the-counter pain relievers (such as ibuprofen or acetaminophen) as substances with a specific, documented interaction with Cormin.


Q: Are there specific foods I should avoid while on Cormin?

There are no specific food avoidance requirements listed in the core regulatory prescribing information for Cormin. Official guidance for the oral form is to take it with or without food.

How should Cormin be stored and disposed of?

How to Store and Dispose of Cormin?

Cormin must be stored according to regulatory requirements to maintain its stability and effectiveness as a Methylcobalamin preparation.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (typically below 25 C or 30 C).
Protection Protect from Light and moisture.
Container Keep in the original container and ensure the lid is tightly closed.
Prohibited The injection solution must not be frozen.

Child Safety and Disposal

All forms of the medicine must be stored strictly out of the sight and reach of children. Unused or expired Cormin must be disposed of via an official drug take-back program or specific regulatory household disposal procedures. The product must not be disposed of by pouring it into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cormin found in:

A-Z Index: